In This Section

Program

Saturday, January 9, 2021

Sunday, January 10, 2021

Monday, January 11, 2021

Tuesday, January 12, 2021

Saturday, January 9, 2021

Opening Keynote Address
6:15-7 P.M.

Deconvoluting the tumor microenvironment to enhance immunotherapy
Jeffrey W. Pollard, University of Edinburgh, Edinburgh, Scotland

Opening Reception
7-9 P.M.

Sunday, January 10, 2021

Continental Breakfast
7-8 A.M.
Plenary Session 1: The Organ-Specific Metastatic Niches – They Are Not All Created Equal
8-10:25 A.M.

Title to be announced
Joan Massagué, Memorial Sloan Kettering Cancer Center, New York, New York

Title to be announced
Rosandra N. Kaplan, National Cancer Institute Center for Cancer Research, Bethesda, Maryland

Title to be announced
Sheila A. Stewart, Washington University in St. Louis, St. Louis, Missouri

Title to be announced
Yibin Kang, Princeton University, Princeton, New Jersey

Short talks proffered from abstracts

Break
10:25-10:55 A.M.
Plenary Session 2: Systemic Drivers of Progression – Aging to Obesity
10:55 AM-12:55 P.M.

Linking obesity-associated inflammation with cancer metastasis
Daniela Quail, McGill University, Montreal, QC, Canada

Cellular senescence in cancer therapy: friend or foe?
Marco Demaria, ERIBA, University Medical Center Groningen, Groningen, The Netherlands

Title to be announced
Ashani Weeraratna, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

Short talks proffered from abstracts

Poster Session A / Lunch
12:55-3 P.M.
Workshops
3-4:30 P.M.
  1. Mentoring and beyond, round table 
  2. NCI, where are the next funding paradigms, how does the scientist communicate with the NCI to identify new areas of investigation?
  3. The Industrial – Academic Divide, how do we build a bridge?
Plenary Session 3: Tumor progression – Mechano-Signaling and Control
4:30-6:55 P.M.

ECM collagen matrix remodeling during breast cancer progression
Greg D. Longmore, Washington University School of Medicine, St. Louis, Missouri

Microenvironmental control of ECM dynamics and their role in tumor progression and metastasis
Claudia Fischbach-Teschl, Cornell University, Ithaca, New York

Title to be announced
Valerie M. Weaver, University of California, San Francisco, San Francisco, California

Mechanics, multinucleation, and metastasis
Celeste M. Nelson, Princeton University, Princeton, New Jersey

Short talks proffered from abstracts

Evening on Own
6:55 P.M.

Monday, January 11, 2021

Continental Breakfast
7-8 A.M.
Plenary Session 4: Longitudinal Monitoring of the Elusive Tumor Cells
8-10 A.M.

Title to be announced
Mikala Egeblad, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York

Additional speakers to be announced

Short talks proffered from abstracts

Break
10-10:30 A.M.
Plenary Session 5: The Tumor Microenvironment Drives Tumor Cell Fate
10:30 AM-12:30 P.M.

Title to be announced
Peter Croucher, Garvin Institute of Medical Research, Darlinghurst, NSW, Australia

Overcoming immune evasion of dormant, disseminated tumor cells
Cyrus M. Ghajar, Fred Hutchinson Cancer Research Center, Seattle, Washington

Title to be announced
Julio A. Aguirre-Ghiso, Icahn School of Medicine at Mount Sinai, New York, New York

Short talks proffered from abstracts

Lunch on Own
12:30-2:30 P.M.
Plenary Session 6: The Systemic Tumor Microenvironment
2:30-5:30 P.M.

Therapeutic Responses Determined by the Tumor Microenvironment
Sandra S. McAllister, Brigham and Woman’s Hospital, Boston, Massachusetts

Local and systemic effects of cancer-secreted extracellular miRNA
Emily Shizhen Wang, University of California at San Diego, San Diego, California

Title to be announced
David C. Lyden, Weill Cornell Medicine, New York, New York

Short talks proffered from abstracts

Poster Session B/Reception
5:30-7:30 P.M.

Tuesday, January 12, 2021

Continental Breakfast
7-8 A.M.
Plenary Session 7: The Immune Tumor Microenvironment – Blood-Derived versus Tissue-Resident
8-9:45 A.M.

Title to be announced
David G. Denardo, Washington University School of Medicine, St. Louis, Missouri

Title to be announced
Andy J. Minn, Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania

Title to be announced
Michael DuPage, University of California at Berkeley, Berkeley, California

Short talks proffered from abstracts

Break
9:45-10 A.M.
Plenary Session 8: The Therapy-Treated Tumor Microenvironment – Impact on the Preneoplastic versus Premetastatic Niche
10 A.M.-12:10 P.M.

Radiotherapy effects on tumor microenvironment
Silvia C. Formenti, Weill Cornell Medicine, New York, New York

Genetic variants in the tumor microenvironmental alter radiation responses in breast cancer
Carmon Bergom, Medical College of Wisconsin, Milwaukee, Wisconsin

Targeting senescence heterogeneity against therapy-resistant cancer
Peter L.J. De Keizer, University Medical Center Utrecht, Utrecht, The Netherlands

Immune escape during breast tumor progression
Kornelia Polyak, Dana-Farber Cancer Institute, Boston, MA

Short talks proffered from abstracts

Closing Keynote Address
12:10-12:55 P.M.

 Cancer and aging: Rival demons?
Judy Campisi, Buck Institute for Research on Aging, Novato, California

Closing Remarks
12:55 P.M.